Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP518259.RAK-9LF0IiHqLesBqma1dgnsE9LHdl39ds11pyTqbxdhA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP518259.RAK-9LF0IiHqLesBqma1dgnsE9LHdl39ds11pyTqbxdhA130_assertion type Assertion NP518259.RAK-9LF0IiHqLesBqma1dgnsE9LHdl39ds11pyTqbxdhA130_head.
- NP518259.RAK-9LF0IiHqLesBqma1dgnsE9LHdl39ds11pyTqbxdhA130_assertion description "[In conclusion, TET2, DNMT3A and ASXL1 mutations are also present in mastocytosis and these mutations may affect prognosis, as demonstrated by worse OS in mutated patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP518259.RAK-9LF0IiHqLesBqma1dgnsE9LHdl39ds11pyTqbxdhA130_provenance.
- NP518259.RAK-9LF0IiHqLesBqma1dgnsE9LHdl39ds11pyTqbxdhA130_assertion evidence source_evidence_literature NP518259.RAK-9LF0IiHqLesBqma1dgnsE9LHdl39ds11pyTqbxdhA130_provenance.
- NP518259.RAK-9LF0IiHqLesBqma1dgnsE9LHdl39ds11pyTqbxdhA130_assertion SIO_000772 22905207 NP518259.RAK-9LF0IiHqLesBqma1dgnsE9LHdl39ds11pyTqbxdhA130_provenance.
- NP518259.RAK-9LF0IiHqLesBqma1dgnsE9LHdl39ds11pyTqbxdhA130_assertion wasDerivedFrom befree-20140225 NP518259.RAK-9LF0IiHqLesBqma1dgnsE9LHdl39ds11pyTqbxdhA130_provenance.
- NP518259.RAK-9LF0IiHqLesBqma1dgnsE9LHdl39ds11pyTqbxdhA130_assertion wasGeneratedBy ECO_0000203 NP518259.RAK-9LF0IiHqLesBqma1dgnsE9LHdl39ds11pyTqbxdhA130_provenance.